Ascentage Pharma Group International (AAPGV): Bathi sing dikarepake

Ascentage Pharma - logo grafis emiten AAPGV

Earnings expectations for Ascentage Pharma Group (AAPGV) reflect market sentiment, where the value of 0.03 expresses the metric level. Hematologists highly value the scientific contribution of Ascentage Pharma Group (AAPGV) to the development of targeted therapies. The brand is recognized as a global leader in the therapy of resistant leukemias through the blocking of apoptosis proteins. The strategy is based on the launch of innovative BCL-2 drugs for the US and Chinese markets.

AAPGV - Penghasilan resik sing dikarepake Ascentage ing rentang 25.01.2025 - 28.11.2025

Rincian analitis lan laporan data perusahaan Ascentage (AAPGV)

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:Ascentage, AAPGV
Produk merek Ascentage Pharma Group Ltd

Market expectations for Ascentage Pharma Group (AAPGV) often precede current financial results. The indicator is based on consensus net income per share forecasts, where expected marginal profit visualizes the trajectory of future returns. The upward trend of the line confirms fundamental stability, although peak values increase the risk of capital stagnation. The high authority of Ascentage Pharma Group in oncohematology converts scientific potential into analyst optimism, making this metric a key measure of the investment attractiveness of its therapeutic developments.

Pesaing Ascentage Pharma Group

Bathi mangsa ngarep ONC|HALO: Penghasilan resik sing dikarepake|Bathi mangsa ngarep RVMD (RevMed)|AAPG (Ascentage) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CGON (cgoncology.com)|URGN - Bathi mangsa ngarep|BCAX: Bathi mangsa ngarep|PSNL - Proyeksi bathi mangsa ngarep|Erasca Corp (ERAS) - Bathi sing dikarepake|Delcath - Penghasilan resik sing dikarepake|YMAB (Y-mAbs Therapeutics Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Aura Biosciences, Inc. AURA|Proyeksi bathi mangsa ngarep CADL|Proyeksi bathi mangsa ngarep Accuray (ARAY)|Bathi sing dikarepake SELLAS Life Sciences Group Inc. SLS|ACTU - Bathi mangsa ngarep|CTOR: Bathi mangsa ngarep|Penghasilan resik sing dikarepake HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Bathi mangsa ngarep|Bathi resik sing dikarepake Fate Therapeutics Corp (FATE)|Bathi mangsa ngarep WHWK|Prakiraan bathi resik TCRX (TScan Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep CSBR|XBIT - Bathi resik sing dikarepake|CEL-SCI Corporation - Bathi mangsa ngarep|Penghasilan resik sing dikarepake OSTX|radiopharmtheranostics.com - Proyeksi bathi mangsa ngarep|ARTV: Bathi sing dikarepake|ANL (adlainortye.com) - Bathi mangsa ngarep|VERU - Prakiraan bathi perusahaan|TPST (Tempest Therapeutics, Inc.) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep xiliotx.com|Bathi sing dikarepake Enochian BioSciences (RENB)|Bathi sing dikarepake MURA (Mural Oncology PLC)|Bathi sing dikarepake Kairos Pharma Ltd KAPA|Proyeksi bathi mangsa ngarep OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan Curis CRIS|APLM: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Tharimmune, Inc.|ADVB (Advanced Biomed) - Proyeksi bathi mangsa ngarep|Genprex - Bathi forward|Bathi sing dikarepake calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Bathi resik sing dikarepake|PPBT: Bathi mangsa ngarep|Penghasilan resik sing dikarepake AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Bathi sing dikarepake|Checkpoint Therapeutics, Inc (CKPT) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake Elevation Oncology, Inc.|ICAD: Penghasilan resik sing dikarepake|Bathi sing dikarepake ikenaoncology.com (IKNA)|Bathi sing dikarepake NTBL (Notable Labs, Ltd.)|Proyeksi bathi mangsa ngarep VIRX (viracta.com)|MOR - Bathi mangsa ngarep|NAYA - Bathi sing dikarepake